Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial

详细信息    查看全文

• 作者：M. Carcao ; M. Zak ; F. Abdul Karim ; H. Hanabusa ; S. Kearney ; M.-Y. Lu ; P. Persson ; S. Rangarajan and E. Santagostino
• 刊名：Journal of Thrombosis and Haemostasis
• 出版年：2016
• 出版时间：August 2016
• 年：2016
• 卷：14
• 期：8
• 页码：1521-1529
• 全文大小：288K
• ISSN：1538-7836

文摘

Nonacog beta pegol is a recombinant glycoPEGylated factor IX with an extended half-life, developed to improve care for patients with hemophilia B.